Home Infusion Therapy Market Is Projected to Grow at A CAGR of 8.6% By 2032

The global Home Infusion Therapy market size was valued at US$ 31 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 8.6% from 2022 to 2032. Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Billion during 2022 - 2032.

The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing administrations. Broad rounds of essential and far reaching optional exploration have been utilized by the examiners at Fact.MR to show up at different assessments and projections for Demand of Home Infusion Therapy Market both at worldwide and provincial levels.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: -https://www.factmr.com/connectus/sample?flag=S&rep_id=7169?PJ

𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗛𝗼𝗺𝗲 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗮𝗿𝗸𝗲𝘁:

Patient Preference and Convenience: The primary driver of the home infusion therapy market is the growing preference among patients for receiving treatments in the comfort of their homes. Home infusion allows patients to avoid lengthy hospital stays, reducing disruption to their daily lives and providing a sense of autonomy.

Rise in Chronic Diseases: The increasing prevalence of chronic diseases, such as autoimmune disorders, cancer, and neurological conditions, has fueled the demand for long-term therapeutic interventions. Home infusion therapy enables the management of these conditions outside traditional healthcare settings, promoting a more patient-centric approach.

Advancements in Infusion Technology: Technological advancements in infusion devices and therapies have expanded the range of conditions that can be effectively treated through home infusion. Innovations in infusion pumps, monitoring systems, and drug formulations contribute to the safety and efficacy of home-based treatments.

Healthcare Cost Containment: Home infusion therapy offers cost-effective solutions for both healthcare providers and payers. By shifting certain treatments from hospitals or clinics to patients' homes, healthcare costs associated with facility-based care can be reduced, contributing to overall healthcare cost containment efforts.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: -

CVS/Coram
Option Care Health
BriovaRx/Diplomat
PharMerica
Fresenius Kabi
ICU Medical, Inc.
B. Braun Melsungen AG
Baxter
BD
Caesarea Medical Electronics
Smiths Medical
Terumo Corporation
JMS Co. Ltd.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀

To retain market share and broaden their product range, significant players commonly adopt techniques such as mergers, acquisitions, and new product releases.

Some of the recent developments of key Home Infusion Therapy providers are as follows:

In May 2021, Smiths Medical and Ivenix, Inc. announced a partnership to deliver a comprehensive range of infusion management solutions to the U.S. market. The goal of this partnership is to enhance infusion administration and patient safety.

In March 2021, PromptCare purchased NBN Infusions, Inc, a home infusion and respiratory treatment service provider located in New Jersey. NBN Infusions, Inc. specialises in providing infusion treatment to critically ill patients. PromptCare will gain market share in the Northeastern United States as a result of this transaction.

In December 2021, Baxter International announced the purchase of Hillrom. It will help the firm extend its global reach while also integrating medical device innovations to improve patient care, save costs, and streamline operations.

In February 2020, Avoset created a homecare system, AvosetGO, an infusion pump device with embedded touch displays that can be connected and monitored via smart devices.

In March 2021 Terumo and Glooko, a company that creates remote patient monitoring software and mobile apps, formed a technical agreement to provide diabetes data solutions throughout the world. As a result of the collaboration, data from Terumo's diabetes care devices will be linked into Glooko's diabetic data management platform, Diasend.

In May 2020, the Australian Therapeutic Goods Administration awarded the Evo IQ Syringe Infusion System CE marking and marketing approval.

Similarly, recent developments related to companies offering Home Infusion Therapy have been tracked by the team at Fact.MR, which are available in the full report.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝗛𝗼𝗺𝗲 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀

𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝘆𝗽𝗲 :
Infusion Pumps
Elastomeric
Electromechanical
Gravity
Other Infusion Pumps
Intravenous Sets
IV Cannulas
Needless Connectors

𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗧𝘆𝗽𝗲 :
Anti-Infective
Endocrinology
Hydration Therapy
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Other Applications

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝘀

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU - (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)

𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗿𝗲𝗻𝗱𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗛𝗼𝗺𝗲 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗮𝗿𝗸𝗲𝘁:

Looking ahead, the home infusion therapy market is poised to witness several trends:

Advancements in Infusion Pump Technology: Continued advancements in infusion pump technology are anticipated, with a focus on enhancing the usability, portability, and connectivity of devices used in home infusion therapy. Smart pumps with integrated connectivity features may become more widespread.

Remote Monitoring and Telehealth Integration: The integration of remote monitoring tools and telehealth platforms is expected to increase. This allows healthcare providers to remotely track patient progress, address concerns in real-time, and provide virtual consultations, promoting proactive and personalized care.

Biologic and Specialty Drug Infusions: The rise in the use of biologic and specialty drugs for various conditions is likely to drive the demand for home infusion services. As these therapies become more prevalent, the need for specialized home infusion capabilities and expertise will increase.

Personalized and Targeted Therapies: Advances in personalized medicine and targeted therapies may lead to the development of infusion treatments tailored to individual patient profiles. Home infusion providers may play a crucial role in delivering these customized therapies to patients in a home setting.

Increased Collaboration with Specialty Pharmacies: Collaboration between home infusion providers and specialty pharmacies is expected to grow. This collaboration can streamline the procurement and delivery of specialty medications, ensuring that patients receive the right medications at the right time.

Global Expansion of Home Infusion Services: The global expansion of home infusion services is likely, driven by the recognition of the benefits of home-based care and the increasing prevalence of chronic diseases worldwide. Efforts to establish regulatory frameworks and standardize practices will be key to supporting this expansion.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7169?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.